Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

Biosyent Inc is a growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn and Tibella.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSXV:RX)

Fundamentals Snapshot (TSXV:RX)

Opinion & Analysis (TSXV:RX)

VANC Pharmaceuticals could earn 75% net margin with OTC iron supplement

The Life Sciences Report March 29, 2016

Most oil storage in at least 80 years?

Stockhouse Editorial April 1, 2015

Bullboard Posts (TSXV:RX)

RE:RE:share buyback

Karren411 - May 2, 2022

BioSyent to Present

MISSISSAUGA, Ontario, April 26, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will...
Betteryear2 - April 26, 2022

RE:RE:RE:share buyback

They were a few small sales by Wilson and Raghubir around the time of the annual share grant (RSUs). Hardly cause for concern. The three...
microcap - April 13, 2022

RE:RE:RE:RE:share buyback

Dividend?
overnout - April 13, 2022

RE:RE:RE:share buyback

Why would execs exercise options with $9.12 strike price and years to expiry?   
lscfa - April 13, 2022

RE:share buyback

Nice that they still see value in buying shares back north of $8
overnout - April 13, 2022